Navigation Links
Viagra improves high altitude exercise performance up to 45% for some

Sildenafil (Viagra) significantly improved the cardiovascular and exercise performance measures of trained cyclists at high altitude, mostly because the drug helped some participants improve a lot -- up to 45% -- while others showed little change. Sildenafil provided no benefit at sea level.

Ten cyclists who took sildenafil at altitude collectively lowered the time it took to cover six kilometers by 15% compared to placebo trials at altitude. The cyclists also significantly improved stroke volume (the volume of blood moved out of one ventricle of the heart per beat) and cardiac output (stroke volume times heart rate) compared to the placebo trial. Sildenafil also minimized the decline of arterial oxygen saturation of the arteries when the cyclists were at simulated altitude of 12,700 feet.

But the researchers discovered that these improvements occurred largely because some people achieve major gains with sildenafil at altitude while others improve much less or not at all. The responders improved 39% in the time trial performance at altitude compared to their performance at altitude with a placebo. Some in the responder group improved as much as 45%, according to a study in the Journal of Applied Physiology published by The American Physiological Society. Non-responders improved an insignificant 1%.

The study, "Sildenafil improves cardiac output and exercise performance during acute hypoxia but not normoxia," by Andrew R. Hsu, Kimberly E. Barnholt, and Nicolas K. Grundmann, Veterans Affairs Palo Alto Health Care System; Joseph H. Lin and Stewart W. McCallum, Stanford University Medical Center; and Anne L. Friedlander, Veterans Affairs Palo Alto Health Care System and Stanford University appears in the June issue of the Journal of Applied Physiology.

Drug expands the blood vessels
Sildenafil citrate is best known as Viagra, a drug used to treat erectile dysfunction. The drug was originally developed to relieve high blood press
'"/>

Source:American Physiological Society


Page: 1 2 3 4

Related biology news :

1. Viagras hidden help for wildlife
2. Product improves peptide identification for proteomics research
3. Stem cell treatment improves mobility after spinal cord injury
4. Combination therapy improves AIDS-related lymphoma outcome
5. One fish, two fish: New MIT sensor improves fish counts
6. Man-made heart tissue improves cardiac performance
7. Quitting smoking improves lung function considerably
8. Melatonin improves mood in winter depression
9. Brain protein improves stroke symptoms in rats, even when injected after 3 days
10. Heart smart: new drug improves blood flow
11. Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows

Post Your Comments:
(Date:11/4/2009)... What,s the cost of saving a teena...ath resulting from prescription medication abuse, ..., however, may be unaware that the lock-boxes they...the ticking timebomb of prescription drugs. That,s...ity medical supplies, has formed an exclusive part...
(Date:11/4/2009)...ntists at the University of North Carolina at Chap...alifornia, San Francisco have developed and experi...diseases for existing drugs. , The researchers d...similar the structures of all known drugs are to t...s ligands -- of disease targets within the cell. I...
(Date:11/3/2009)...ember 4, 2009) For more than 25 years, all attemp...mbus gigas ) have been unsuccessfuluntil now. For ...niques to produce beaded (nucleated) and non-beade...eveloped by scientists from Florida Atlantic Unive...I). With less than two years of research and exper...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 1Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 2Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 3Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 4Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 5Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 1Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 2Scientists discover new genetic immune disorder in children 8716 1Scientists discover new genetic immune disorder in children 8716 2Scientists discover new genetic immune disorder in children 8716 3
... have discovered the first microRNAs tiny bits of...of 10 major degenerative muscular disorders, openi... understanding of these debilitating, poorly under...e published online this week by the Proceedings of... Eisenberg, PhD, of the Program in Genomics at Chi...
... October 17, 2007A late-breaking symposium, Colony...tus, Potential Causes, and Preventive Measures, ha...f the Entomological Society of America (ESA), to b... headed by entomologists Diana Cox-Foster (Penn St...xplore possible factors that may have caused honey...
...n, DC. Ocean Conservancy Scientist, Wallace J. Nic...rcher Hoyt Peckham found surprising results in a r...at Nichols and Peckham conducted over the course o...tober 17 in the online, open-access journal PLoS O... operations are a greater threat to the survival o...
Other Biology News:Massive microRNA scan uncovers leads to treating muscle degeneration 2Research shows loggerhead sea turtles threatened by small-scale fishing operations 2
(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...
(Date:11/5/2009)...ember 5, 2009 at 4:30 p.m. Eastern Time , BOT...l/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" ...unaudited financial results for the third quarter ...wed the Company,s highlights for the third quarter... reflect the operations of OncoGenex Technologies ...
(Date:11/5/2009)... Senomyx, Inc. (Nasdaq: ...te receptor-based technologies to discover novel f...edient supply industries, today provided a corpora...hird quarter ended September 30, 2009. Revenues w...mpared to $4.0 million for the third quarter of 20...
(Date:11/5/2009)...y and vision correction experts listed in the Trus...d at the recently concluded American Academy of Op...isco, California. Dr. Stephen Brint, MD, Dr. Frede...r. Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr. ...dward Manche, MD, and Dr. Parag Majmudar, MD, all ...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...alif., Sept. 18 InterMune, Inc.,(Nasdaq: ITMN ) ... market,and other conditions, 3,000,000 shares of ...g. The Company expects to grant the underwriters,a...,000 shares of common,stock in connection with the...be sold by InterMune. Goldman, Sachs & Co. is act...
...alif., Sept. 18 Dynavax,Technologies Corporation ...Vice President and Chief Financial Officer, will p...Global Life Sciences Conference in New York, New,Y...n Daylight Savings Time,(6:30 a.m. PDST). The pres...o broadcast and the subsequent archived audio,reco...
...as, Sept. 18 Luminex Corporation,(Nasdaq: LMNX )...he fourth,annual America,s Growth Capital Emerging...in Boston. The investor presentation by Patrick J... and Harriss T. Currie, chief financial officer, w...eptember 20, 2007. The,presentation will be webcas...
Other Biology Technology:InterMune Announces Proposed Public Offering of Common Stock 2Dynavax to Present at UBS 2007 Global Life Sciences Conference 2Luminex Corporation to Present at America's Growth Capital Emerging Growth Conference 2
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Phosphothreonine-X-Phosphotyrosine Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Rabbit Anti-Human ADAMTS-4, disintegrin-like domain Antibody, Unconjugated from CHEMICON
Biology Products: